About
Critical Pressure is a biopharmaceutical company developing drugs to treat vascular dysfunction and shock, focusing initially on severe sepsis by utilizing technology designed to avoid harmful effects linked to excess fluid administration.
Explore Critical Pressure's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.